Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS | RA CAPITAL MANAGEMENT L.P. | 766,834 1.200% | 766,834 (New Position) | Filing History |
| 2024-11-14 4:32 pm Purchase | 2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS | BIOTECHNOLOGY VALUE FUND L P | 883,844 1.300% | 883,844 (New Position) | Filing History |
| 2024-11-14 2:35 pm Sale | 2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS | DAFNA Capital Management LLC | 895,200 1.370% | -215,849 (-19.43%) | Filing History |
| 2024-11-12 4:45 pm Unchanged | 2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS | The Vanguard Group | 4,088,760 6.240% | 0 (Unchanged) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS | BlackRock Inc. BLK | 4,081,038 6.200% | 0 (Unchanged) | Filing History |
| 2024-11-04 1:46 pm Purchase | 2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS | The Vanguard Group | 4,088,760 6.240% | 4,088,760 (New Position) | Filing History |
| 2024-10-24 2:02 pm Purchase | 2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS | BlackRock Inc. BLK | 4,081,038 6.200% | 4,081,038 (New Position) | Filing History |
| 2024-10-11 4:02 pm Purchase | 2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS | Octagon Capital Advisors LP | 4,263,701 6.500% | 4,263,701 (New Position) | Filing History |
| 2024-04-10 10:06 am Unchanged | 2024-04-09 | 13G | Regulus Therapeutics Inc. RGLS | FMR LLC | 2,922,600 4.464% | 0 (Unchanged) | Filing History |
| 2024-03-25 4:18 pm Purchase | 2024-03-14 | 13G | Regulus Therapeutics Inc. RGLS | RA CAPITAL MANAGEMENT L.P. | 6,250,000 9.500% | 6,250,000 (New Position) | Filing History |
| 2024-03-22 4:03 pm Purchase | 2024-03-12 | 13G | Regulus Therapeutics Inc. RGLS | Deep Track Capital, LP | 6,888,424 9.990% | 6,888,424 (New Position) | Filing History |
| 2024-03-20 4:30 pm Purchase | 2024-03-14 | 13G | Regulus Therapeutics Inc. RGLS | Vivo Opportunity Fund Holdings L.P. | 5,000,000 7.700% | 5,000,000 (New Position) | Filing History |
| 2024-03-18 9:13 pm Purchase | 2024-03-14 | 13D | Regulus Therapeutics Inc. RGLS | Growth Equity Opportunities V LLC | 6,533,102 9.990% | 4,587,523 (+235.79%) | Filing History |
| 2024-02-14 2:54 pm Purchase | 2023-12-31 | 13G | Regulus Therapeutics Inc. RGLS | DAFNA Capital Management LLC | 1,111,049 5.490% | 1,111,049 (New Position) | Filing History |
| 2024-02-09 09:49 am Purchase | 2024-02-08 | 13G | Regulus Therapeutics Inc. RGLS | FMR LLC | 2,922,600 14.452% | 727,600 (+33.15%) | Filing History |
| 2024-02-06 11:06 am Purchase | 2023-12-31 | 13G | Regulus Therapeutics Inc. RGLS | Victory Capital Management, Inc. | 1,155,516 5.710% | 305,319 (+35.91%) | Filing History |
| 2024-01-18 10:25 am Purchase | 2023-12-31 | 13G | Regulus Therapeutics Inc. RGLS | FEDERATED HERMES INC. FHI | 4,023,860 19.900% | 148,282 (+3.83%) | Filing History |
| 2023-05-12 1:57 pm Purchase | 2023-04-13 | 13D | Regulus Therapeutics Inc. RGLS | Growth Equity Opportunities V LLC | 1,945,579 9.990% | 487,327 (+33.42%) | Filing History |
| 2023-05-10 09:58 am Purchase | 2023-04-30 | 13G | Regulus Therapeutics Inc. RGLS | FEDERATED HERMES INC. FHI | 3,875,578 19.900% | 970,752 (+33.42%) | Filing History |
| 2023-02-01 11:43 am Sale | 2022-12-31 | 13G | Regulus Therapeutics Inc. RGLS | FEDERATED HERMES INC. FHI | 2,904,826 17.250% | -1 (-0.00%) | Filing History |